Global Cardiac Mapping Systems Market Report and Forecast 2024-2032

Global Cardiac Mapping Systems Market

The global cardiac mapping systems market was estimated to be worth USD 1.84 billion in 2023. By 2032, the market value is anticipated to be worth USD 3.84 billion, rising at a CAGR of 8.50% in the forecast period of 2024-2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Company News

• In April 2023, Royal Philips launched a novel cardiac mapping system, KODEX-EPD, for enhanced imaging techniques. This will assist the physicians in getting precise information before the ablation procedures.

• In January 2023, FDA approved Abbott’s new cardiac mapping system, the Ensite X electrophysiology system. This system will help detect and manage cardiac arrhythmias by producing a detailed three-dimensional image of the heart.

• In January 2023, Medtronic, one of the leading key players, announced its acquisition with Affera, a Boston-based MedTech company, to expand its cardiac mapping systems product portfolio.

Introduction

Cardiac mapping systems are the mapping devices used to measure the heart’s electrical impulses and create an extensive three-dimensional image of the heart’s anatomy. These systems map the different cardiac arrhythmias, including tachycardia, bradycardia, and premature ventricular contractions.

Cardiac mapping systems are non-invasive and need to be placed on the chest. Cardiac mapping helps detect the spatial and temporal areas during a specific heart rhythm. The healthcare technician can perform cardiac mapping on the required area of interest for a particular heart rhythm.

A cardiac mapping system generally consists of several equipments like amplifiers, recorders, and analysing systems or analysers. Cardiac mapping is performed with the help of catheters. These catheters are inserted into the heart chambers to record the electrocardiograms, which can be visualised on screen.

The cardiac data analysis on the screen is being done to study the heart's anatomy. These catheters can be localised or positioned using the fluoroscopy technique.

According to the cardiac mapping systems market research report, the market can be categorised into the following segments:

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Type

• Contact Cardiac Mapping Systems

• Electroanatomical Mapping Systems

• Traditional Endocardial Catheter Mapping Systems

• Basket Catheter Mapping Systems

• Non-Contact Cardiac Mapping Systems

Market Breakup by Indication Type

• Atrial Flutter

• Atrioventricular Nodal Reentry Tachycardia (AVNRT)

• Atrial Fibrillation

• Other Arrhythmias

Market Breakup by End-User

• Hospitals

• Testing Laboratories

• Research Laboratories

• Individual

Market Breakup by Region

• North America

• United States of America

• Canada

• Europe

• United Kingdom

• Germany

• France

• Italy

• Others

• Asia Pacific

• China

• Japan

• India

• ASEAN

• Australia

• Others

• Latin America

• Brazil

• Argentina

• Mexico

• Others

• Middle East and Africa

• Saudi Arabia

• United Arab Emirates

• Nigeria

• South Africa

• Others

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increased Prevalence of Cardiovascular Diseases and Rise in Product Launches are Aiding the Market Growth

Rising Prevalence of Cardiovascular Disorders

The increasing prevalence of cardiovascular disorders drives the cardiac mapping systems market growth. According to the European Health Network, around 19 million people suffer from cardiovascular diseases every year. With the growing population, there is an increase in the incidence of cardiac disorders. This is further propelling the market growth.

Product Launches and Approvals

Due to the extensive research by clinical scientists, novel products are being discovered. The launch of these products will help in the expansion of the cardiac mapping systems market. For example, in 2020, a leading company, BioSense Webster, launched a new cardiac mapping system that is more efficient than conventional cardiac mapping systems.

Another key factor boosting the growth of this market is product approvals. The regulatory bodies of different countries have become more cooperative and approved more products, thus increasing the cardiac mapping systems market size.

For example, Abbott got approval for its cardiac mapping system, Ensite X, in Australia and Europe, providing significant impetus to the market growth.

Therapeutic Landscape

Cardiac mapping is a broad term covering several types of mapping. The different modes of cardiac mapping are epicardial, endocardial, and body surface mapping.

Modes of Cardiac Mapping Systems

There are different modes in cardiac mapping systems. Some of the major modes in cardiac mapping systems include activation mapping, entrainment mapping, and pace mapping.

Activation mapping works on the principle of electrocardiogram tracings to detect the direction and type of impulse propagation. Entrainment mapping is used to visualise the location of the circuit, which can be helpful while performing ablation. Pace mapping is another mode in which the tachycardia sources are plotted by pacing at several endocardial sites.

The cardiac mapping systems help visualise and analyse the heart’s electrical activity. This data is used to diagnose and manage cardiovascular disorders at the early stages or at the onset of that disease.

These devices also help map the heart’s anatomy before and after the ablation process. This mapping is done to ensure whether the surgery is effective or not.

Treatment Of Cardiac Arrhythmias

The cardiac mapping systems market is majorly driven by its use in treating cardiac arrhythmias. The different arrhythmias managed by these systems include ventricular tachycardia, atrial fibrillation, ventricular bradycardia, and untimely ventricular contractions.

With the high treatment potential, the cardiac mapping systems market possesses an excellent opportunity for healthcare industries and pharmaceutical companies in extensive therapeutic and diagnostic methods.

Latest Industry Trends Include the Rapid Technological Advancements, Incorporation of 3-D Technology and Hybrid Systems

Rising Technological Advancements

Increasing technological advancements have paved the way for multiple approaches to cardiac mapping systems. These novel technologies provide more specific and sensitive data. The technological advancements have resulted in the production of magnetic-based mapping systems and impedance-based mapping systems., which have further aided the market growth.

Incorporation Of Three-Dimensional technology

The 3-D technology is used to create highly detailed images of the heart’s anatomy, which helps cardiologists detect abnormal heart rhythm regions. Such technology is likely to provide an impetus to the market growth in the coming years as well.

The Invention of Hybrid Systems

The emergence of hybrid magnetic and impedance-based systems has provided novel prospects in the cardiac mapping systems market. This incorporated system is being used to create the heart’s anatomical map. In this system, a magnetic system is used to get the accurate image, while impedance systems help provide users with flexibility for using any catheter.

With the advancements in electrophysiology, novel and more effective technologies have been invented. These technologies are under clinical trials and, once approved, are anticipated to drive the growth of the market during the forecast period.

Competitive Landscape

The report gives an in-depth analysis of the key players involved in the cardiac mapping systems market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• Biosense Webster

• Abbott Laboratories

• Medtronics PLC

• Boston Scientific Corporation

• Acutus Medical

• Microport Scientific Corporation

• CoreMap Inc.

• APN Health LLC

• BioSig Technologies Inc.

• Biotronik SE and Co KG

• Koninklijke Philips NV

• Angiodynamics

Key Highlights of the Report